We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CDNA market cap is 787.55M. The company's latest EPS is USD -3.6750 and P/E is -4.14.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 82.38M | 77.26M | 70.3M | 67.19M | 65.57M |
| Operating Income | -18.82M | -24.32M | -27.62M | -28.78M | -122.63M |
| Net Income | -18.03M | -23.75M | -24.95M | -23.49M | -118.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 127.07M | 192.19M | 296.4M | 321.79M | 280.32M |
| Operating Income | -24.53M | -22.53M | -29.73M | -77.23M | -203.36M |
| Net Income | -21.97M | -18.71M | -30.66M | -76.61M | -190.28M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 542.99M | 528.22M | 514.82M | 501.18M | 466.83M |
| Total Liabilities | 112.08M | 108.2M | 109.61M | 107.05M | 205.5M |
| Total Equity | 430.91M | 420.02M | 405.21M | 394.13M | 261.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 151.74M | 368.51M | 566.62M | 542.99M | 466.83M |
| Total Liabilities | 52.74M | 90.83M | 100.75M | 112.08M | 205.5M |
| Total Equity | 99M | 277.68M | 465.88M | 430.91M | 261.33M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.24M | 671k | 172k | -10.01M | -18.39M |
| Investing | -228.5M | -14.77M | 577k | -921k | 40.45M |
| Financing | -4.54M | -1.14M | -2.7M | -2.73M | -29.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.77M | 33.43M | -19.29M | -25.24M | -18.39M |
| Investing | -22.58M | -100.39M | 47.71M | -228.5M | 40.45M |
| Financing | -132k | 163.15M | 185.64M | -4.54M | -29.61M |
| Market Cap | 787.55M |
| Price to Earnings Ratio | -4.14 |
| Price to Sales Ratio | 2.81 |
| Price to Cash Ratio | 9.59 |
| Price to Book Ratio | 3.02 |
| Dividend Yield | - |
| Shares Outstanding | 51.78M |
| Average Volume (1 week) | 654.22k |
| Average Volume (1 Month) | 903.95k |
| 52 Week Change | 79.15% |
| 52 Week High | 17.03 |
| 52 Week Low | 4.80 |
| Spread (Intraday) | 0.32 (2.07%) |
| Company Name | CareDx Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.caredx.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
